Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2533]

FDA grants fast track designation to drug combo for colorectal cancer

FDA grants fast track designation to drug combo for colorectal cancer

Colorectal cancer evades immunotherapy using a dual barrier

Colorectal cancer evades immunotherapy using a dual barrier

Researchers uncover key mechanism behind chemotherapy-induced nerve damage

Researchers uncover key mechanism behind chemotherapy-induced nerve damage

ESMO 2025: Colon cancer DNA detectable in blood can guide chemo decisions: study

ESMO 2025: Colon cancer DNA detectable in blood can guide chemo decisions: study

ESMO 2025: Roundup of MSK's research, including lung and pancreatic cancer treatments

ESMO 2025: Roundup of MSK's research, including lung and pancreatic cancer treatments

Two-drug combination could improve colorectal cancer therapy

Two-drug combination could improve colorectal cancer therapy

ESMO 2025: Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer

ESMO 2025: Combination of immunotherapy and targeted therapy improves survival for patients with advanced...

Global study challenges ‘cancer epidemic’ in young adults – with one exception

Global study challenges ‘cancer epidemic’ in young adults – with one exception

ESMO 2025: Blood test guides post-surgical immunotherapy for muscle-invasive bladder cancer

ESMO 2025: Blood test guides post-surgical immunotherapy for muscle-invasive bladder cancer

ESMO 2025: DNA shed by colon cancers may help personalise postsurgical treatment

ESMO 2025: DNA shed by colon cancers may help personalise postsurgical treatment

More from ecancer